Your browser doesn't support javascript.
loading
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
Starr, Jessica A; Pinner, Nathan A; Lisenby, Katelin M; Osmonson, Alyssa.
Affiliation
  • Starr JA; Auburn University Harrison School of Pharmacy, Birmingham, Alabama, USA.
  • Pinner NA; Auburn University Harrison School of Pharmacy, Birmingham, Alabama, USA.
  • Lisenby KM; Auburn University Harrison School of Pharmacy, Tuscaloosa, Alabama, USA.
  • Osmonson A; PGY2 Internal Medicine Resident, Birmingham, Alabama, USA.
Pharmacotherapy ; 41(6): 526-536, 2021 06.
Article in En | MEDLINE | ID: mdl-33866578

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke Volume / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Pharmacotherapy Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke Volume / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Pharmacotherapy Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States